In cardiac-arrest survivors [40], NHR showed a higher ROC-AUC of 0.74, outperforming CRP (0.58) and slightly exceeding IL-6 (0.69), indicating better prediction of adverse outcomes. The gene discussed is IL6; the disease is cardiac arrest.